Sun, Yuchen
Saito, Kosuke
Ushiki, Atsuhito
Abe, Mitsuhiro
Saito, Yoshinobu
Kashiwada, Takeru
Horimasu, Yasushi
Gemma, Akihiko
Tatsumi, Koichiro
Hattori, Noboru
Tsushima, Kenji
Takemoto, Kazuhisa
Ishikawa, Rika
Momiyama, Toshiko
Matsuyama, Shin-ichiro
Arakawa, Noriaki
Akane, Hirotoshi
Toyoda, Takeshi
Ogawa, Kumiko
Sato, Motonobu
Takamatsu, Kazuhiko
Mori, Kazuhiko
Nishiya, Takayoshi
Izumi, Takashi
Ohno, Yasuo
Saito, Yoshiro
Hanaoka, Masayuki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP15-19mk0101045, JP20-22mk0101173, JP23mk0121256)
Japan Society for the Promotion of Science (JP22K15289)
Article History
Received: 10 August 2023
Accepted: 24 December 2023
First Online: 14 January 2024
Declarations
:
: This study was performed in line with the principles of the 1964 Declaration of Helsinki. This study was approved by the Ethics Committees of the National Institute of Health Sciences (NIHS) (Nos. 257 and 259 for NIHS and Nos. 261 and 263 for Kihara Memorial Yokohama Foundation), Shinshu University (Nos. 3318 and 4716), Nippon Medical School (No. 27-11-514), Chiba University (No. 2265), Hiroshima University (No. E-245), Daiichi Sankyo Co., Ltd (No. 15-0504-00), and Astellas Pharma Inc. (No. 000043). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Motonobu Sato and Kazuhiko are employees of Astellas Pharma, Inc. Kazuhiko Mori and Takayoshi Nishiya are employees of Daiichi Sankyo RD Novare Co. Ltd. No other conflicts of interest are declared.